Insulet $419 million repurchases of convertible senior notes
We advised the agent on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Visen Pharmaceutical HK$783.3 million IPO
The shares are listed on the HKEX
Insulet $450 million senior notes offering
The high-yield notes are due 2033
Integer Holdings $1 billion convertible senior notes offering
The 1.875% convertible senior notes are due 2030
Beam Therapeutics $500 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Tenaya Therapeutics $52.5 million units offering
The units comprise common stock and warrants
Denali Therapeutics $400 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Recursion Pharmaceuticals $500 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares